CT45A6
gene geneOn this page
Also known as CT45-6CT45.6
Summary
CT45A6 (cancer/testis antigen family 45 member A6, HGNC:33271) is a protein-coding gene on chromosome Xq26.3, encoding Cancer/testis antigen family 45 member A6 (P0DMU7).
Located in nucleus.
Source: NCBI Gene 541465 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_001017438
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33271 |
| Approved symbol | CT45A6 |
| Name | cancer/testis antigen family 45 member A6 |
| Location | Xq26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CT45-6, CT45.6 |
| Ensembl gene | ENSG00000278289 |
| Ensembl biotype | protein_coding |
| OMIM | 300797 |
| Entrez | 541465 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000612878, ENST00000620654
RefSeq mRNA: 1 — MANE Select: NM_001017438
NM_001017438
CCDS: CCDS35407
Canonical transcript exons
ENST00000620654 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003713939 | 135802511 | 135802787 |
| ENSE00003720190 | 135796180 | 135796273 |
| ENSE00003720629 | 135794685 | 135794955 |
| ENSE00003723753 | 135798825 | 135798999 |
| ENSE00003736639 | 135796655 | 135796903 |
Expression profiles
Bgee: expression breadth broad, 35 present calls, max score 91.11.
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.11 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.13 | gold quality |
| right testis | UBERON:0004534 | 63.18 | gold quality |
| nucleus accumbens | UBERON:0001882 | 62.30 | gold quality |
| testis | UBERON:0000473 | 57.62 | gold quality |
| caudate nucleus | UBERON:0001873 | 57.62 | gold quality |
| putamen | UBERON:0001874 | 55.75 | gold quality |
| left testis | UBERON:0004533 | 54.63 | gold quality |
| hypothalamus | UBERON:0001898 | 52.10 | gold quality |
| adenohypophysis | UBERON:0002196 | 47.74 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 45.17 | gold quality |
| pituitary gland | UBERON:0000007 | 43.39 | gold quality |
| Ammon’s horn | UBERON:0001954 | 41.36 | gold quality |
| amygdala | UBERON:0001876 | 39.93 | gold quality |
| temporal lobe | UBERON:0001871 | 39.80 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 39.73 | gold quality |
| brain | UBERON:0000955 | 39.43 | gold quality |
| prefrontal cortex | UBERON:0000451 | 38.16 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| substantia nigra | UBERON:0002038 | 35.52 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.27 | gold quality |
| frontal cortex | UBERON:0001870 | 34.77 | gold quality |
| cerebral cortex | UBERON:0000956 | 33.32 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 33.10 | gold quality |
| muscle tissue | UBERON:0002385 | 32.45 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6308 | yes | 217.11 |
| E-HCAD-5 | yes | 151.27 |
| E-ANND-3 | no | 0.06 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting CT45A6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-5572 | 98.55 | 65.84 | 970 |
| HSA-MIR-6819-5P | 97.96 | 66.59 | 1071 |
| HSA-MIR-3151-3P | 97.80 | 66.16 | 479 |
| HSA-MIR-6737-5P | 97.75 | 66.54 | 1044 |
| HSA-MIR-6812-5P | 97.56 | 65.39 | 1059 |
| HSA-MIR-3674 | 97.01 | 68.86 | 1171 |
| HSA-MIR-6747-5P | 96.17 | 64.99 | 743 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ct45a | ENSMUSG00000064016 |
| rattus_norvegicus | Ct45a9 | ENSRNOG00000048059 |
| drosophila_melanogaster | IntS6 | FBGN0261383 |
| caenorhabditis_elegans | WBGENE00000994 |
Paralogs (11): INTS6 (ENSG00000102786), INTS6L (ENSG00000165359), SAGE1 (ENSG00000181433), CT45A5 (ENSG00000228836), CT45A1 (ENSG00000268940), CT45A3 (ENSG00000269096), CT45A10 (ENSG00000269586), CT45A9 (ENSG00000270946), CT45A2 (ENSG00000271449), CT45A7 (ENSG00000273696), CT45A8 (ENSG00000278085)
Protein
Protein identifiers
Cancer/testis antigen family 45 member A6 — P0DMU7 (reviewed: P0DMU7)
Alternative names: Cancer/testis antigen 45-6, Cancer/testis antigen 45A6
All UniProt accessions (1): P0DMU7
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Testis specific. Expressed in cancer cell lines.
Similarity. Belongs to the CT45 family.
RefSeq proteins (1): NP_001017438* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029307 | INT_SG_DDX_CT_C | Domain |
| IPR051113 | Integrator_subunit6 | Family |
Pfam: PF15300
UniProt features (7 total): sequence conflict 3, region of interest 2, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DMU7-F1 | 70.23 | 0.23 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
chrXq26, HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL, HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CT45A6 | AP3B1 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0FKI7, A2YX04, A5WUN7, A5WV69, A7J1T2, C5DZR8, E9Q555, F4J6F6, O43310, O48767, P0DMS1, P0DMU7, P0DMU8, P0DMU9, P0DMV0, P0DMV1, P0DMV2, Q0V9S3, Q12912, Q14693, Q1LXZ9, Q2NKQ1, Q2PFD7, Q3TEL6, Q502L1, Q5DJT8, Q5R7V3, Q5T8D3, Q5XG73, Q621Z7, Q640U0, Q641E3, Q6IRN6, Q6Z8M8, Q700C2, Q758T8, Q80Y56, Q811D2, Q8AV28, Q8BLN6
Diamond homologs: A6NJ88, P0DMU7, P0DMU8, P0DMU9, P0DMV0, P0DMV1, P0DMV2, Q2TAF4, Q5DJT8, Q5HYN5, Q5JSJ4, Q5U4W6, Q6PCM2, Q7SYD9, Q8BND4, Q8NHU0, Q9NXZ1, Q9UL03, Q54Z23, Q9W485
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
326 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:135796176:T:G | donor_loss | 1.0000 |
| X:135796177:G:A | donor_loss | 1.0000 |
| X:135796177:G:GG | donor_gain | 1.0000 |
| X:135796182:GCAAG:G | donor_gain | 1.0000 |
| X:135796188:G:GT | donor_gain | 1.0000 |
| X:135796216:G:GT | donor_gain | 1.0000 |
| X:135796272:G:GA | acceptor_gain | 1.0000 |
| X:135796272:GA:G | acceptor_gain | 1.0000 |
| X:135796272:GAA:G | acceptor_gain | 1.0000 |
| X:135796272:GAAT:G | acceptor_gain | 1.0000 |
| X:135796272:GAATA:G | acceptor_gain | 1.0000 |
| X:135796273:A:AG | acceptor_gain | 1.0000 |
| X:135796273:AG:A | acceptor_loss | 1.0000 |
| X:135796275:TCAGA:T | acceptor_loss | 1.0000 |
| X:135796276:TTCA:T | acceptor_loss | 1.0000 |
| X:135796278:T:G | acceptor_gain | 1.0000 |
| X:135796279:A:AG | acceptor_gain | 1.0000 |
| X:135796280:C:G | acceptor_gain | 1.0000 |
| X:135796281:A:AG | acceptor_gain | 1.0000 |
| X:135796282:A:AG | acceptor_gain | 1.0000 |
| X:135796651:T:G | donor_loss | 1.0000 |
| X:135796652:G:GG | donor_gain | 1.0000 |
| X:135796653:AG:A | donor_loss | 1.0000 |
| X:135796654:AA:A | donor_gain | 1.0000 |
| X:135796902:GA:G | acceptor_gain | 1.0000 |
| X:135794954:G:GT | acceptor_gain | 0.9900 |
| X:135794954:GAT:G | acceptor_gain | 0.9900 |
| X:135794954:GATG:G | acceptor_gain | 0.9900 |
| X:135794954:GATGT:G | acceptor_gain | 0.9900 |
| X:135794955:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1160326636 (X:135798230 G>A), RS1162495330 (X:135797175 T>C), RS1164063770 (X:135797435 C>A), RS1167466060 (X:135797482 T>A), RS1167792028 (X:135803146 C>A,T), RS1170442447 (X:135803173 G>A), RS1171797734 (X:135797631 A>G), RS1174753406 (X:135797640 G>T), RS1182480199 (X:135797651 G>A), RS1184222867 (X:135798771 T>C), RS1188832379 (X:135797386 C>G,T), RS1191535195 (X:135803477 G>A), RS1192222600 (X:135797446 G>A), RS1192317667 (X:135797494 A>G), RS1192522630 (X:135797441 C>G,T)
Disease associations
OMIM: gene MIM:300797 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.